Company: BIAF
Filing Date: 2025-10-09
Form Type: 424B5
Source: 0001493152-25-017591
Chunk: 15

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-10-09
Form: 424B5
Chunk 15
---
 accompanying prospectus or the registration statement of which this prospectus supplement and the accompanying prospectus form a part, has not been approved and/or endorsed by us or WallachBeth, and should not be relied upon by investors.

Our directors and officers have entered into lock-up agreements. Under these agreements, these individuals have agreed, subject to specified exceptions, not to sell or transfer any shares of common stock or securities convertible into, or exchangeable or exercisable for, our common stock during a period ending 60 days after the date of the closing of this offering, without first obtaining the written consent of WallachBeth. Specifically, these individuals have agreed, in part, not to:

| ● | sell,                                                                                                                                       
 offer, contract or grant any option to sell (including any short sale), pledge, transfer, establish an open “put equivalent                 
 position” within the meaning of Rule 16a-l(h) under the Exchange Act;                                                                       |
| ● | enter                                                                                                                                       
 into any swap or other agreement, arrangement, hedge or transaction that transfers to another, in whole or in part, directly or indirectly, 
 any of the economic consequences of ownership of our securities, whether any such transaction is to be settled by delivery of shares        
 of our common stock, in cash or otherwise;                                                                                                  |
| ● | publicly                                                                                                                                    
 announce the intention to make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge; or                    |
| ● | other                                                                                                                                       
 arrangement relating to any of our securities.                                                                                              |

Notwithstanding these limitations, these shares of common stock may be transferred under limited circumstances, including, without limitation, by gift, will or intestate succession.

Additionally, pursuant to the terms of the placement agency agreement (the “Placement Agency Agreement”) with WallachBeth, subject to certain exceptions, until November 14, 2025, we may not issue, enter into any agreement to issue, or announce the issuance or proposed issuance of any shares of common stock or Common Stock Equivalents (as defined in the Placement Agency Agreement), or, subject to certain exceptions, file any registration statement. We have also agreed, subject to certain exceptions, not to enter into a Variable Rate Transaction (as defined in the Placement Agency Agreement) for 6 months after the closing date of this offering, provided, however, that the prohibition on “at-the-market offerings” and the issuance of common stock pursuant to an equity line of credit shall expire on the six-month anniversary of the closing date